Congenital pseudarthrosis of the tibia: biological and biomechanical considerations to achieve union and prevent refracture

D Paley, D Paley

Abstract

Congenital pseudarthrosis of the tibia (CPT) is likely to be a primary periosteal disease and secondary bone disease. The primary goal of treatment is to obtain union, correct the diaphyseal deformity, correct any proximal fibular migration and prevent refracture. The pathobiology demonstrates increased osteoclasis by the surrounding fibrous hamartoma and reduced osteogenesis and bone morphogenic protein production by the bone. This leads to a loss of remodelling potential and gradual bowing and atrophy of the bone with eventual fracture of the tibia and or fibula. This recommends the synergistic use of bisphosphonates and bone morphogenic protein. The pathomechanics of CPT implicate the anterolateral bowing, narrow diameter of the atrophic bone ends and proximal fibular migration. These biomechanical factors can be addressed by means of straightening of the deformity, intramedullary support of both bones, stable fixation and reduction of proximal migration of the fibula. A summary of the literature on CPT shows that the mean probability of achieving primary union without refracture, by most treatments is 50% (12% to 80%). Two recent studies have shown a much higher success rate approaching 100%, by creating a cross-union between the tibia and fibula. The cross-union with intramedullary reinforcement of the bone makes refracture unlikely due to the cross-sectional area of union with its two-bar linkage. A new classification to guide such treatment is also proposed.

Level of evidence: V - expert opinion.

Keywords: congenital pseudarthrosis of the tibia; cross-union; neurofibromatosis.

Figures

Fig. 1
Fig. 1
Paley Classification of congenital pseudarthrosis of the tibia: type 1, no fractures; type 2, no fracture tibia, fracture fibula with fibula (a) at station (b) proximal migration; type 3, fracture tibia, no fracture fibula ; type 4, fracture tibia and fibula with fibula (a) at station (b) proximal migration (c) bone defect tibia with proximal migration fibula. Reproduced with permission by the Paley Foundation (AP, anteroposterior; LAT, lateral).
Fig. 2
Fig. 2
Reproduced with permission by the Paley Foundation: (a) anterior incision shown from front and cross section. Note hamartoma encircling tibia and fibula and the interosseous membrane between them; (b) anterior and deep posterior fasciotomy and muscle reflection to expose tibia, interosseous membrane, and fibula, allow resection of the membrane under direct vision without damage to the neurovascular bundles; (c) circumferential resection of the tibial fibrous hamartoma is carried out over the planned length of the cross-union. The same is done for the fibular hamartoma; (d) the tibial bowing is straightened and the bone ends overlapped and resected; (e) a customized Fassier-Duval telescopic nail is inserted and the male end locked with a wire into the distal epiphysis and the female end screwed into the proximal epiphysis; (f) a small diameter locking plate is fixed medially to the tibia with six screws; (g) the fibular ends can now be cut and the fibula fixed with a wire in its medullary canal; (h) a periosteal graft is harvested from the undersurface of the iliacus muscle. It is then expanded by passing it through the skin graft mesher; (i) decancellousization of the ilium is done by first splitting the two cortical tables of the ilium down to the roof of the acetabulum, triradiate cartilage, sciatic notch, posterior spines and sacro-iliac joint; (j) the periosteal graft is wrapped around the congenital pseudarthrosis site and bone morphogenic protein-2 (BMP2) collagen sponges are inserted overtop the posterior muscles behind the tibia and fibula (left). The cancellous bone is inserted between the tibia and fibula (left centre). The BMP2 sponges are placed overtop the bone graft (right centre). The anterior muscles lie over the BMP2. The interosseous space has a sandwich of cancellous bone between layers of BMP2 and its overlying soft tissues; (k) the cross-union forms between the bones by three months after surgery. The bone is well fixed with the telescopic rod in the tibia, the wire in the fibula and the plate on the tibia (left). Growth may occur despite the hardware leading to telescopic expansion of the male and female rods. The fibular wire descends with growth (left).
Fig. 3
Fig. 3
Anteroposterior (AP) (right) and lateral (left) radiographs (a) of right tibia and fibula with anterolateral bowing and neurofibromatosis. This is classified as Paley type 1. AP (left) and lateral (right) radiographs (b) one year after osteotomy of the tibia and fibula with cross-union protocol surgery at age two years. The tibia and fibula are straight fixated with the Fassier-Duval nail and an EVOS plate (Smith & Nephew Orthopedics, Memphis, Tennessee). The upper screws in the plate were removed after six months. There is a long tibio-fibular cross-union present.
Fig. 4
Fig. 4
Anteroposterior (AP) (left) and oblique (right) radiographs (a) of right tibia and fibula with anterolateral bowing and neurofibromatosis. The fibula has a pseudarthrosis with a bone defect and has proximal migration. This is classified as Paley type 2b. AP radiograph (b) of tibia and fibula immediately after cross-union surgery three years. Note the large amount of bone graft in the interosseous space. The rod and plate are stabilizing the leg well. The fibular bone defect is spanned by graft and an intramedullary fibular wire. The fibula was moved distally relative to the tibia and is fixed with one of the screws in the plate. AP radiograph (c) taken one year later showing a mature cross-union spanning the interosseous space and the fibular bone defect. The tibia is united end to end. Telescoping is seen in the Fassier-Duval nail indicating growth. The upper screws in the plate were removed after six months.
Fig. 5
Fig. 5
Anteroposterior (AP) (left) and lateral (right) radiographs (a) of left tibia and fibula with anterolateral bowing, neurofibromatosis and tibial pseudarthrosis with an intact fibula. This is classified as Paley type 3. AP radiograph (b) six months after cross-union surgery performed at age five years. AP radiograph (c) one and a half years after cross-union surgery. The plate has been removed. The rod was exchanged for a new Fassier-Duval rod.
Fig. 6
Fig. 6
Anteroposterior (AP) (left) and lateral (right) radiographs (a) of right tibia and fibula with anterolateral bowing and neurofibromatosis. This is classified as Paley type 4b since there is a pseudarthrosis of both bones and the distal fibula has proximal migration. The bones are very osteoporotic. He has been non-ambulatory for three years. AP tibial radiograph (b) six months after cross-union surgery which was performed at age three years. A well healed bony bridge is already seen. AP radiograph (c) one year after cross-union surgery after the upper screws in the plate were removed.

References

    1. Hefti F, Bollini G, Dungl P, et al. . Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data. J Pediatr Orthop B 2000;9:11-15.
    1. Guille JT, Kumar SJ, Shah A. Spontaneous union of a congenital pseudarthrosis of the tibia after Syme amputation. Clin Orthop Relat Res 1998;351:180-185.
    1. McCarthy RE. Amputation for congenital pseudarthrosis of the tibia. Indications and techniques. Clin Orthop Relat Res 1982;4:58-61.
    1. Codivilla A. On the cure of the congenital pseudoarthrosis of the tibia by means of periosteal transplantation. J Bone Jt Surg [Am] 1906;S2-4-A:163-169.
    1. McElvenny R. Congenital pseudarthrosis of the tibia: the findings in one case and a suggestion as to possible etiology and treatment. Q Bull Northwest Univ Med Sch 1949;23:413-423.
    1. Boyd HB. Pathology and natural history of congenital pseudarthrosis of the tibia. Clin Orthop Relat Res 1982;166:5-13.
    1. Boyd HB, Sage FP. Congenital pseudarthrosis of the tibia. J Bone Joint Surg [Am] 1958;40-A:1245-1270.
    1. Blauth M, Harms D, Schmidt D, Blauth W. Light- and electron-microscopic studies in congenital pseudarthrosis. Arch Orthop Trauma Surg 1984;103:269-277.
    1. Ippolito E, Corsi A, Grill F, Wientroub S, Bianco P. Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop B 2000;9:3-10.
    1. El-Rosasy M, Paley D, Herzenberg J. Ilizarov techniques for the management of congenital pseudarthrosis of the tibia. Tanta University; Tanta, Egypt, 2001.
    1. El-Rosasy M, Paley D, Herzenberg J. Congenital pseudarthrosis of the tibia Rozbruch S, Ilizarov S, eds. Limb Lengthening and Reconstruction Surgery. New York: Informa Healthcare, 2007:485-493.
    1. Paterson DC, Lewis GN, Cass CA. Treatment of congenital pseudarthrosis of the tibia with direct current stimulation. Clin Orthop Relat Res 1980;148:129-135.
    1. Weber M. Congenital pseudarthrosis of the tibia redefined: congenital crural segemental dysplasia Rozbruch S, Ilizarov S, eds. Limb Lengthening and Reconstruction Surgery. New York: Informa Healthcare, 2007:495-509.
    1. Thabet AM, Paley D, Kocaoglu M, et al. . Periosteal grafting for congenital pseudarthrosis of the tibia: a preliminary report. Clin Orthop Relat Res 2008;466:2981-2994.
    1. Hermanns-Sachweh B, Senderek J, Alfer J, et al. . Vascular changes in the periosteum of congenital pseudarthrosis of the tibia. Pathol Res Pract 2005;201:305-312.
    1. Cho T-J, Seo J-B, Lee HR, et al. . Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1. J Bone Joint Surg [Am] 2008;90-A:2735-2744.
    1. Schindeler A, Ramachandran M, Godfrey C, et al. . Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type andNf1 haploinsufficient mice. J Orthop Res 2008;26:65-74.
    1. Schindeler A, Birke O, Yu NYC, et al. . Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate. Bone Joint J 2011;93-B:1134-1139.
    1. Madhuri V, Mathew SE, Rajagopal K, Ramesh S, Antonisamy B. Does pamidronate enhance the osteogenesis in mesenchymal stem cells derived from fibrous hamartoma in congenital pseudarthrosis of the tibia? Bone Rep 2016;5:292-298.
    1. Song MH, Park MS, Yoo WJ, Cho T-J, Choi IH. Femoral overgrowth in children with congenital pseudarthrosis of the tibia. BMC Musculoskelet Disord 2016;17:274.
    1. Grill F, Bollini G, Dungl P, et al. . Treatment approaches for congenital pseudarthrosis of tibia: results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B 2000;9:75-89.
    1. Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL. Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study. J Bone Joint Surg [Am] 2004;86-A:1186-1197.
    1. Dormans JP, Krajbich JI, Zuker R, Demuynk M. Congenital pseudarthrosis of the tibia: treatment with free vascularized fibular grafts. J Pediatr Orthop 1990;10:623-628.
    1. El-Gammal TA, El-Sayed A, Kotb MM. Telescoping vascularized fibular graft: a new method for treatment of congenital tibial pseudarthrosis with severe shortening. J Pediatr Orthop B 2004;13:48-56.
    1. Keret D, Bollini G, Dungl P, et al. . The fibula in congenital pseudoarthrosis of the tibia: the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B 2000;9:69-74.
    1. Paterson DC, Simonis RB. Electrical stimulation in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg [Br] 1985;67-B:454-462.
    1. Birke O, Schindeler A, Ramachandran M, et al. . Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia. J Child Orthop 2010;4:507-517.
    1. Das SP, Ganesh S, Pradhan S, Singh D, Mohanty RN. Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: A randomised controlled trial. Int Orthop 2014;38:1987-1992.
    1. Johnston CE. Congenital pseudarthrosis of the tibia: results of technical variations in the charnley-williams procedure. J Bone Joint Surg [Am] 2002;84-A:1799-1810.
    1. Joseph B, Mathew G. Management of congenital pseudarthrosis of the tibia by excision of the pseudarthrosis, onlay grafting, and intramedullary nailing. J Pediatr Orthop B 2000;9:16-23.
    1. Joseph B, Somaraju VVJ, Shetty SK. Management of congenital pseudarthrosis of the tibia in children under 3 years of age: effect of early surgery on union of the pseudarthrosis and growth of the limb. J Pediatr Orthop 2003;23:740-746.
    1. Kim HW, Weinstein SL. Intramedullary fixation and bone grafting for congenital pseudarthrosis of the tibia. Clin Orthop Relat Res 2002;405:250-257.
    1. Liu Y, Mei H, Zhu G, et al. . Congenital pseudarthrosis of the tibia in children: should we defer surgery until 3 years old? J Pediatr Orthop B 2018;27:17-25.
    1. Stephens Richards B, Anderson TD. RhBMP-2 and intramedullary fixation in congenital pseudarthrosis of the tibia. J Pediatr Orthop 2018;38:230-238.
    1. Vigouroux F, Mezzadri G, Parot R, et al. . Vascularised fibula or induced membrane to treat congenital pseudarthrosis of the Tibia: A multicentre study of 18 patients with a mean 9.5-year follow-up. Orthop Traumatol Surg Res 2017;103:747-753.
    1. Boero S, Catagni M, Donzelli O, Facchini R, Frediani PV. Congenital pseudarthrosis of the tibia associated with neurofibromatosis-1: treatment with Ilizarov’s device. J Pediatr Orthop 1997;17:675-684.
    1. Borzunov DY, Chevardin AY, Mitrofanov AI. Management of congenital pseudarthrosis of the tibia with the Ilizarov method in a paediatric population: influence of aetiological factors. Int Orthop 2016;40:331-339.
    1. Hissnauer TN, Stiel N, Babin K, et al. . Bone morphogenetic protein-2 for the treatment of congenital pseudarthrosis of the tibia or persistent tibial nonunion in children and adolescents: A retrospective study with a minimum 2-year follow-up. J Mater Sci Mater Med 2017;28:60.
    1. Ohnishi I, Sato W, Matsuyama J, et al. . Treatment of congenital pseudarthrosis of the tibia: a multicenter study in Japan. J Pediatr Orthop 2005;25:219-224.
    1. Paley D, Catagni M, Argnani F, et al. . Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique. Clin Orthop Relat Res 1992;280:81-93.
    1. Agashe MV, Song SH, Refai MA, Park KW, Song HR. Congenital pseudarthrosis of the tibia treated with a combination of Ilizarov’s technique and intramedullary rodding. Acta Orthop 2012;83:515-522.
    1. Shabtai L, Ezra E, Wientroub S, Segev E.. Congenital tibial pseudarthrosis, changes in treatment protocol. J Pediatr Orthop B 2015;24:444-449.
    1. Yan A, Mei HB, Liu K, et al. . Wrapping grafting for congenital pseudarthrosis of the tibia. Medicine (Baltimore) 2017;96:e8835.
    1. Zhu GH, Mei HB, He RG, et al. . Combination of intramedullary rod, wrapping bone grafting and Ilizarov’s fixator for the treatment of Crawford type IV congenital pseudarthrosis of the tibia: mid-term follow up of 56 cases. BMC Musculoskelet Disord 2016;17:443.
    1. Kalra GD, Agarwal A. Experience with free fibula transfer with screw fixation as a primary modality of treatment for congenital pseudarthosis of tibia in children - Series of 26 cases. Indian J Plast Surg 2012;45:468-477.
    1. Weiland AJ, Weiss AP, Moore JR, Tolo VT. Vascularized fibular grafts in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg [Am] 1990;72-A:654-662.
    1. Lee FY-I, Sinicropi SM, Lee FS, et al. . Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases. J Bone Joint Surg [Am] 2006;88-A:627-633.
    1. Högler W, Yap F, Little D, et al. . Short-term safety assessment in the use of intravenous zoledronic acid in children. J Pediatr 2004;145:701-704.
    1. Carlier A, Vasilevich A, Marechal M, De Boer J, Geris L. In silico clinical trials for pediatric orphan diseases. Sci Rep 2018;8:2465.
    1. Westberry DE, Carpenter AM, Tisch J, Wack LI. Amputation outcomes in congenital pseudarthrosis of the tibia. J Pediatr Orthop 2018;38:e475-e481.
    1. Shah H, Joseph B, Nair BVS, et al. . What factors influence union and refracture of congenital pseudarthrosis of the tibia? A multicenter long-term study. J Pediatr Orthop 2018;38:e332-e337.
    1. Kesireddy N, Kheireldin RK, Lu A, et al. . Current treatment of congenital pseudarthrosis of the tibia. J Pediatr Orthop B 2018;27:541-550.
    1. Karol LA, Haideri NF, Halliday SE, Smitherman TB, Johnston CE 2nd. Gait analysis and muscle strength in children with congenital pseudarthrosis of the tibia: the effect of treatment. J Pediatr Orthop 1998;18:381-386.
    1. Seo SG, Lee DY, Kim YS, et al. . Foot and ankle function at maturity after Ilizarov treatment for atrophic-type congenital pseudarthrosis of the tibia a comprehensive outcome comparison with normal controls. J Bone Joint Surg [Am] 2016;98:490-498.
    1. Andersen KS. Radiological classification of congenital pseudarthrosis of the tibia. Acta Orthop Scand 1973;44:719-727.
    1. Crawford AH, Bagamery N. Osseous manifestations of neurofibromatosis in childhood. J Pediatr Orthop 1986;6:72–88.
    1. Choi IH, Cho T-J, Moon HJ. Ilizarov treatment of congenital pseudarthrosis of the tibia: a multi-targeted approach using the Ilizarov technique. Clin Orthop Surg 2011;3:1-8.
    1. Paley D, Catagni MA, Argnani F, et al. . Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop Relat Res 1989;241:146-165.
    1. Grill F, Ganger R, Petje G, Schmid R. Congenital pseudarthrosis of the tibia. Orthopade 2000;29:821-831.
    1. Wientroub S, Grill F. Congenital pseudarthrosis of the tibia: Part 1. European Pediatric Orthopaedic Society multicenter study of congenital pseudoarthrosis. J Pediatr Orthop B 2000;9:1-2.
    1. Morrissy RT. Congenital pseudarthrosis of the tibia. Factors that affect results. Clin Orthop Relat Res 1982;166:21-27.
    1. Gray JC, Elves MW. Early osteogenesis in compact bone isografts: a quantitative study of contributions of the different graft cells. Calcif Tissue Int 1979;29:225-237.
    1. Choi IH, Lee SJ, Moon HJ, et al. . ‘4-in-1 Osteosynthesis’ for atrophic-type congenital pseudarthrosis of the tibia. J Pediatr Orthop 2011;31:697-704.
    1. Paley D. Congenital pseudarthrosis of the tibia: combined pharmacologic and surgical treatment using biphosphonate intravenous infusion and bone morphogenic protein with periosteal and cancellous autogenous bone grafting, tibio-fibular cross union, intramedullary rodding and external fixation In Zorzi A. (ed.), 2012: 91-106; InTech, Available from:
    1. Paley D. Congenital pseudarthrosis of the tibia Current Progress in Orthopaedics. Johari A and Waddell J. (eds) Mumbai: Tree Life Media; 2017:318-348.
    1. Packer D, Robb J, Liu R, Robbins C, Paley D. Combined pharmacologic and biological treatment of congenital pseudoarthrosis of the tibia; 100 % union; no refractures! J Child Orthop 2016;10:S19-S20.
    1. Schindeler A, Little DG. Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1). Bone 2008;42:616-622.
    1. Johnston CE, Birch JG. A tale of two tibias: a review of treatment options for congenital pseudarthrosis of the tibia. J Child Orthop 2008;2:133-149.
    1. Stiel N, Hissnauer TN, Rupprecht M, et al. . Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics. J Mater Sci Mater Med 2016;27:184.

Source: PubMed

3
Subskrybuj